Dr. Steven Brenisen Long, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 9690 Ventana Way, Alpharetta, GA 30022 Phone: 770-623-6773 Fax: 770-232-9882 |
Dr. William Charles Parrish, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1325 Sherry Dr, Alpharetta, GA 30004 Phone: 770-475-7100 Fax: 770-475-6718 |
Moshe Bachar, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 3180 N Point Pkwy, Ste 302, Alpharetta, GA 30005 Phone: 404-800-5181 Fax: 404-800-5797 |
Dr. Kimberly J Green, D.O General Practice Medicare: May Accept Medicare Assignments Practice Location: 1090 Cambridge Sq, Suite A, Alpharetta, GA 30009 Phone: 770-754-9880 Fax: 770-754-9881 |
Elizabeth M Board, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 5755 N Point Pkwy, Suite 74, Alpharetta, GA 30022 Phone: 770-667-3006 Fax: 770-667-3311 |
Ms. Katherine Ashley Cherry, DVM General Practice Medicare: Not Enrolled in Medicare Practice Location: 3785 Hamby Rd, Alpharetta, GA 30004 Phone: 770-521-1314 |
Dr. Margaret Renee Acker, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 6240 Shiloh Rd, Alpharetta, GA 30005 Phone: 855-422-5628 |
News Archive
The Saints are going to the Super Bowl and we couldn't be any happier. We wanted to throw out a small lagniappe for our fellow Louisiana residents and offer the free drug card program titled the WhoDatDrugCard.com . This card is available to all residents and can save you as much as 75% off your medication purchase at over 2,000 pharmacies statewide.
Topical retinoids, which target retinoic acid receptors, are commonly used to treat acne. New research published in theBritish Journal of Dermatologyreveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety profile compared with less selective retinoids.
The first study to closely follow toxicity markers in smokers who replace tobacco for e-cigarettes is seeking volunteers.
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.
› Verified 2 days ago